1. People's Republic of China Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Changjiang Pharmaceutical Group Co., Ltd.

Changjiang Pharmaceutical Group Co., Ltd.

300391.SZ
Changjiang Pharmaceutical Group Co., Ltd.CN flagShenzhen Stock Exchange
0.19
CNY
- -
- -
66.56MMarket Cap
Changjiang Pharmaceutical Group Co., Ltd.
300391.SZ
(Shenzhen Stock Exchange)

Recent

price

0.19

P/E

ratio

- -

div

yld

- -

ROIC.AI

2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
FRC
9.5
0.95
1.19
1.2
1.36
1.02
0.76
1.11
2.64
3.82
2.07
3.47
6.74
4.61
3.42
0.32
0.31
Revenue per Share
1.32
0.17
0.2
0.19
0.19
0.12
0.02
0.02
0.25
0.44
-1.91
0.07
0.14
-0.07
-1.73
-1.79
-1.69
Basic EPS, GAAP
-0.06
-0.01
-0.01
-0.08
-0.2
-0.3
0.07
-0.15
0.12
0.56
0.05
0.04
0.25
-0.34
-0.44
-0.23
- -
Free Cash Flow per Basic Share
0.59
0.07
0.1
0.1
0.12
0.07
0.1
0.07
0.05
0.09
0.08
0.04
0.11
0.16
0.18
0.1
0.06
Dividend per Share
4.61
0.37
0.49
0.63
0.74
0.76
1.1
1.31
1.34
2.2
-0.16
-0.09
0.05
-0.02
-1.75
-3.54
-3.87
Book Value per Share
4.73
0.57
0.72
0.87
0.93
1.37
1.29
1.52
0.96
3.37
1.96
1.93
2.41
2.7
1.95
-1.47
-1.87
Tangible Book Value per Share
13
186
188
187
187
239
251
211
282
231
350
350
350
351
350
350
350
Basic Weighted Avg Shares
128
178
223
225
255
243
191
235
744
881
725
1,215
2,362
1,615
1,198
112
109
Sales/Revenue/Turnover
16.91
18.61
19.19
19.71
18.51
15.92
-0.36
-1.12
11.78
14.94
-5.51
7.65
12.8
11.39
6.61
-118.69
-126.81
Operating Margin (%)
9
10
12
14
14
15
20
26
38
43
43
43
60
115
46
37
- -
Depreciation Expense
18
31
37
35
35
29
5
4
70
102
-670
25
49
-23
-606
-628
-592
Net Income, GAAP
7.67
10.31
12.49
10.81
10.34
7.66
- -
- -
2.62
14.5
- -
- -
- -
37.94
- -
- -
- -
Effective Tax Rate (%)
13.87
17.35
16.64
15.75
13.69
11.8
2.63
1.8
9.37
11.58
-92.33
2.08
2.08
-1.44
-50.57
-562.56
-545.15
Profit Margin (%)
-12
46
104
81
-14
62
87
67
-68
417
350
-510
-51
197
248
-795
-1,009
Working Capital
- -
40
83
40
20
- -
75
50
25
- -
- -
345
332
341
524
446
376
LT Debt
71
117
145
173
198
365
364
363
934
1,432
752
1,449
1,609
1,665
1,017
-421
-563
Total Equity
- -
14.26
14.76
13
11.13
7.15
- -
- -
9.29
7.73
- -
- -
- -
4.57
- -
- -
- -
Return on Invested Capital (%)
- -
21.02
23.35
18.4
14.47
11.78
- -
- -
14.05
16.56
- -
- -
- -
-3.25
- -
- -
- -
Return on Capital (%)
- -
46.84
45.73
33.66
27.19
17.89
2.19
1.52
21.34
23.08
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
ST Debt
304
304
265
LT Borrowings
444
444
375
LT Finance Leases
1
1
1
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
350
350
350
Market Capitalization
1,766
1,927
1,541

Working Capital

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
Total Current Assets
1,129
1,185
1,150
Cash, Cash Equivalents & STI
8
9
10
Accounts Receivable, Net
980
1,023
991
Inventories
42
47
56
Total Current Liabilities
1,925
2,045
2,160
Payables & Accruals
- -
- -
- -
ST Debt
304
304
265
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
8.96%
-14.62%
-141.42%
Free Cash Flow
-17.21%
53.33%
-48.44%
Net Income, GAAP
309.15%
469.76%
3.68%
Sales/Revenue/Turnover
23.27%
2.76%
-90.68%
Total Cash Common Dividend
23.4%
31.14%
-41.61%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
137
339
546
176
1,198
2024
59
15
27
11
112
2025
46
25
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
-0.07
- -
- -
- -
-1.73
2024
-0.14
- -
- -
- -
-1.79
2025
-0.17
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
0.03
- -
- -
- -
0.18
2024
0.03
- -
- -
- -
0.1
2025
0.01
- -
- -
- -
- -
Similar Companies
ChengDu ShengNuo Biotec Co.,Ltd. (688117.SS)
Tikun Olam-Cannbit Pharmaceuticals Ltd. (TKUN.TA)
Aprogen Biologics Inc. (003060.KS)
Torrent Pharmaceuticals Limited (TORNTPHARM.BO)
Aion Therapeutic Inc. (ANTCF)
Renhe Pharmacy Co., Ltd. (000650.SZ)
Business
Changjiang Pharmaceutical Group Co., Ltd. (300391.SZ) engages in the production and distribution of pharmaceuticals and photovoltaic equipment in China and internationally. The company offers core products including photovoltaic equipment such as laminating machines and stitch welding machines; pharmaceutical products comprising tablets, hollow capsules, and Chinese herbal beverages; and pharmaceutical distribution services. It operates primarily in the healthcare and drug manufacturing industry, with a focus on specialty and generic drugs, targeting domestic markets in China and select international regions. Founded in 1963 and headquartered in Shouguang, China, the company maintains operations through subsidiaries and employs approximately 352 people. In March 2023, the company underwent a significant reorganization, changing its name from Kangyue Technology Co., Ltd. to Changjiang Pharmaceutical Group Co., Ltd., reflecting a strategic shift toward pharmaceutical expansion. Previously, it completed the acquisition of a 52.8% stake in Hubei Changjiangxing Pharmaceutical Co., Ltd. from Hubei Changjiang Pharmacy Chain Co., Ltd., enhancing its presence in pharmaceutical distribution and related services.